{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:33:21Z","timestamp":1790112801685,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T00:00:00Z","timestamp":1433721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/npp.2015.148","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T07:01:42Z","timestamp":1433746902000},"page":"2948-2959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":174,"title":["A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects"],"prefix":"10.1038","volume":"40","author":[{"given":"Bogna M","family":"Ignatowska-Jankowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma L","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Kinsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeshna","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad M","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Poklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Zanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zanato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain R","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron H","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,8]]},"reference":[{"key":"BFnpp2015148_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/jnc.12115","volume":"124","author":"KH Ahn","year":"2013","unstructured":"Ahn KH, Mahmoud MM, Samala S, Lu D, Kendall DA (2013). Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor. J Neurochem 124: 584\u2013589.","journal-title":"J Neurochem"},{"key":"BFnpp2015148_CR2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1124\/mol.112.080879","volume":"83","author":"GL Baillie","year":"2013","unstructured":"Baillie GL, Horswill JG, Anavi-Goffer S, Reggio PH, Bolognini D, Abood ME et al (2013). CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity. Mol Pharmacol 83: 322\u2013338.","journal-title":"Mol Pharmacol"},{"key":"BFnpp2015148_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/09540260902782752","volume":"21","author":"ZD Cooper","year":"2009","unstructured":"Cooper ZD, Haney M (2009). Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Int Rev Psychiatry 21: 104\u2013112.","journal-title":"Int Rev Psychiatry"},{"key":"BFnpp2015148_CR4","doi-asserted-by":"publisher","first-page":"9371","DOI":"10.1073\/pnas.161191698","volume":"98","author":"BF Cravatt","year":"2001","unstructured":"Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR et al (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98: 9371\u20139376.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2015148_CR5","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946\u20131949.","journal-title":"Science"},{"key":"BFnpp2015148_CR6","doi-asserted-by":"publisher","first-page":"S319","DOI":"10.1007\/BF02562332","volume":"34","author":"V Di Marzo","year":"1999","unstructured":"Di Marzo V, De Petrocellis L, Bisogno T, Meick D (1999). Metaboloism of anadamide and 2-arachidonoylglycerol: an historical overview and some recent developments. Lipids 34: S319\u2013S325.","journal-title":"Lipids"},{"key":"BFnpp2015148_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V Di Marzo","year":"2001","unstructured":"Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z et al (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822\u2013825.","journal-title":"Nature"},{"key":"BFnpp2015148_CR8","doi-asserted-by":"publisher","first-page":"e00069","DOI":"10.1002\/prp2.69","volume":"2","author":"Y Ding","year":"2014","unstructured":"Ding Y, Qiu Y, Jing L, Thorn DA, Zhang Y, Li JX (2014). Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats. Pharmacol Res Perspect 2: e00069.","journal-title":"Pharmacol Res Perspect"},{"key":"BFnpp2015148_CR9","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/npp.2010.44","volume":"35","author":"KW1 Falenski","year":"2010","unstructured":"Falenski KW1, Thorpe AJ, Schlosburg JE, Cravatt BF, Abdullah RA, Smith TH et al (2010). FAAH-\/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. Neuropsychopharmacology 35: 1775\u20131787.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015148_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/bph.12492","volume":"171","author":"SG Fagan","year":"2014","unstructured":"Fagan SG, Campbell VA (2014). The influence of cannabinoids on generic traits of neurodegeneration. Br J Pharmacol 171: 1347\u20131360.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2015148_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/FBP.0000000000000027","volume":"25","author":"TF Gamage","year":"2014","unstructured":"Gamage TF, Ignatowska-Jankowska BM, Wiley JL, Abdelrahman M, Trembleau L, Greig IR et al (2014). In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569. Behav Pharmacol 25: 182\u2013185.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2015148_CR12","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni Y, Mechoulam R (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. J Amer Chem Soc 86: 1646\u20131647.","journal-title":"J Amer Chem Soc"},{"key":"BFnpp2015148_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.lfs.2012.06.020","volume":"92","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Wise LE, Chen Y, Gujjar R, Mahadevan A, Cravatt BF et al (2013). The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model. Life Sci 92: 498\u2013505.","journal-title":"Life Sci"},{"key":"BFnpp2015148_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/187152709789824660","volume":"8","author":"J Guindon","year":"2009","unstructured":"Guindon J, Hohmann AG (2009). The endocannabinoid system and pain. CNS Neurol Disorders Drug Targets 8: 403\u2013421.","journal-title":"CNS Neurol Disorders Drug Targets"},{"key":"BFnpp2015148_CR15","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1523\/JNEUROSCI.20-23-08932.2000","volume":"20","author":"RE Hampson","year":"2000","unstructured":"Hampson RE, Deadwyler SA (2000). Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J Neurosci 20: 8932\u20138942.","journal-title":"J Neurosci"},{"key":"BFnpp2015148_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/sj.bjp.0706348","volume":"146","author":"S Holt","year":"2005","unstructured":"Holt S, Comelli F, Costa B, Fowler CJ (2005). Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors. Br J Pharmacol 146: 467\u2013476.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2015148_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.bjp.0707347","volume":"152","author":"JG Horswill","year":"2007","unstructured":"Horswill JG, Bali U, Shaaban S, Keily JF, Jeevaratnam P, Babbs AJ et al (2007). PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats. Br J Pharmacol 152: 805\u2013814.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2015148_CR18","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/sj.bjp.0702228","volume":"125","author":"DM Hutcheson","year":"1998","unstructured":"Hutcheson DM, Tzavara ET, Smadja C, Valjent E, Roques BP, Hanoune J et al (1998). Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol. Br J Pharmacol 125: 1567\u20131577.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2015148_CR19","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/bph.12298","volume":"171","author":"BM Ignatowska-Jankowska","year":"2014","unstructured":"Ignatowska-Jankowska BM, Ghosh S, Crowe MS, Kinsey SG, Niphakis MJ, Abdullah RA et al (2014). In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. Br J Pharmacol 171: 1392\u20131407.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2015148_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/BF00432178","volume":"75","author":"TU Jarbe","year":"1981","unstructured":"Jarbe TU, Swedberg MD, Mechoulam R (1981). A repeated test procedure to assess onset and duration of the cue properties of (\u2212) delta 9-THC, (\u2212) delta 8-THC-DMH and (+) delta 8-THC. Psychopharmacology 75: 152\u2013157.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015148_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.drugalcdep.2014.08.004","volume":"143","author":"L Jing","year":"2014","unstructured":"Jing L, Qiu Y, Zhang Y, Li JX (2014). Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats. Drug Alcohol Depend. 143: 251\u2013256.","journal-title":"Drug Alcohol Depend."},{"key":"BFnpp2015148_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00213-003-1484-0","volume":"169","author":"Z Justinova","year":"2003","unstructured":"Justinova Z, Tanda G, Redhi GH, Goldberg SR (2003). Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology 169: 135\u2013140.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015148_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nm803","volume":"9","author":"S Kathuria","year":"2003","unstructured":"Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A et al (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76\u201381.","journal-title":"Nat Med"},{"key":"BFnpp2015148_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","volume":"25","author":"T Kenakin","year":"2004","unstructured":"Kenakin T (2004). Principles: receptor theory in pharmacology. Trends Pharmacol Sci 25: 186\u2013192.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp2015148_CR25","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1016\/j.ddtec.2012.07.006","volume":"10","author":"T Kenakin","year":"2013","unstructured":"Kenakin T (2013). Analytical pharmacology and allosterism: the importance of quantifying drug parameters in drug discovery. Drug Discov Today Technol 10: e229\u2013e235.","journal-title":"Drug Discov Today Technol"},{"key":"BFnpp2015148_CR26","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.jpain.2010.04.001","volume":"11","author":"SG Kinsey","year":"2010","unstructured":"Kinsey SG, Long JZ, Cravatt BF, Lichtman AH (2010). Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms. J Pain 11: 1420\u20131428.","journal-title":"J Pain"},{"key":"BFnpp2015148_CR27","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1124\/jpet.109.155465","volume":"330","author":"SG Kinsey","year":"2009","unstructured":"Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL et al (2009). Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther 330: 902\u2013910.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2015148_CR28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1124\/jpet.112.201426","volume":"345","author":"SG Kinsey","year":"2013","unstructured":"Kinsey SG, Wise LE, Ramesh D, Abdullah R, Selley DE, Cravatt BF et al (2013). Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects. J Pharmacol Exp Ther 345: 492\u2013501.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2015148_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00213-008-1117-8","volume":"198","author":"D Kota","year":"2008","unstructured":"Kota D, Martin BR, Damaj MI (2008). Age-dependent differences in nicotine reward and withdrawal in female mice. Psychopharmacology 198: 201\u2013210.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015148_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/BF02246292","volume":"119","author":"AH Lichtman","year":"1995","unstructured":"Lichtman AH, Dimen KR, Martin BR (1995). Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119: 282\u2013290.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015148_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1124\/jpet.302.1.73","volume":"302","author":"AH Lichtman","year":"2002","unstructured":"Lichtman AH, Hawkins EG, Griffin G, Cravatt BF (2002). Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J Pharmacol Exp Ther 302: 73\u201379.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2015148_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1124\/jpet.104.069401","volume":"311","author":"AH Lichtman","year":"2004","unstructured":"Lichtman AH, Leung D, Shelton C, Saghatelian A, Hardouin C, Boger D et al (2004). Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J Pharmacol Exp Ther 311: 441\u2013448.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2015148_CR33","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0022-3565(25)13256-4","volume":"247","author":"PJ Little","year":"1988","unstructured":"Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR (1988). Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther 247: 1046\u20131051.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2015148_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nchembio.129","volume":"5","author":"JZ Long","year":"2009","unstructured":"Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE et al (2009a). Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5: 37\u201344.","journal-title":"Nat Chem Biol"},{"key":"BFnpp2015148_CR35","doi-asserted-by":"publisher","first-page":"20270","DOI":"10.1073\/pnas.0909411106","volume":"106","author":"JZ Long","year":"2009","unstructured":"Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X et al (2009b). Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci USA 106: 20270\u201320275.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2015148_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR et al (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83\u201390.","journal-title":"Biochem Pharmacol"},{"key":"BFnpp2015148_CR37","unstructured":"National Research Council (2011). Institutional Animal Care and Use Committees at Virginia Commonwealth University and West Virginia University and were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.."},{"key":"BFnpp2015148_CR38","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/j.1476-5381.2009.00124.x","volume":"156","author":"HA Navarro","year":"2009","unstructured":"Navarro HA, Howard JL, Pollard GT, Carroll FI (2009). Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter. Br J Pharmacol 156: 1178\u20131184.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2015148_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd3624","volume":"11","author":"S Nightingale","year":"2012","unstructured":"Nightingale S (2012). The neuropathic pain market. Nat Rev Drug Discov 11: 101\u2013102.","journal-title":"Nat Rev Drug Discov"},{"key":"BFnpp2015148_CR40","doi-asserted-by":"publisher","first-page":"21134","DOI":"10.1073\/pnas.1202906109","volume":"109","author":"FA Pamplona","year":"2012","unstructured":"Pamplona FA, Ferreira J, Menezes de Lima O Jr, Duarte FS, Bento AF, Forner S et al (2012). Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. Proc Natl Acad Sci USA 109: 21134\u201321139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2015148_CR41","doi-asserted-by":"publisher","first-page":"E625","DOI":"10.1208\/aapsj070364","volume":"7","author":"RG Pertwee","year":"2005","unstructured":"Pertwee RG (2005). The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J 7: E625\u2013E654.","journal-title":"AAPS J"},{"key":"BFnpp2015148_CR42","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1021\/jm201485c","volume":"55","author":"F Piscitelli","year":"2012","unstructured":"Piscitelli F, Ligresti A, La Regina G, Coluccia A, Morera L, Allara M et al (2012). Indole-2-carboxamides as allosteric modulators of the cannabinoid CB(1) receptor. J Med Chem 55: 5627\u20135631.","journal-title":"J Med Chem"},{"key":"BFnpp2015148_CR43","first-page":"353","volume":"39","author":"J Poklis","year":"2015","unstructured":"Poklis J, Clay D, Ignatowska-Jankowska B, Zanato C, Ross R, Greig I et al (2015). HPLC\/MS\/MS Determination of ZCZ-011, a Novel Pharmacological Tool for Investigation the Cannabinoid Receptor in Mouse Brain Using Clean Screen FAStTM Column Extraction. J Chromatography B 39: 353\u2013358.","journal-title":"J Chromatography B"},{"key":"BFnpp2015148_CR44","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1124\/mol.105.016162","volume":"68","author":"MR Price","year":"2005","unstructured":"Price MR, Baillie GL, Thomas A, Stevenson LA, Easson M, Goodwin R et al (2005). Allosteric modulation of the cannabinoid CB1 receptor. Mol Pharmacol 68: 1484\u20131495.","journal-title":"Mol Pharmacol"},{"key":"BFnpp2015148_CR45","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2174\/187152712801661310","volume":"11","author":"G Pryce","year":"2012","unstructured":"Pryce G, Baker D (2012). Potential control of multiple sclerosis by cannabis and the endocannabinoid system. CNS Neurol Disord Drug Targets 11: 624\u2013641.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"BFnpp2015148_CR46","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.tips.2007.10.006","volume":"28","author":"RA Ross","year":"2007","unstructured":"Ross RA (2007a). Allosterism and cannabinoid CB(1) receptors: the shape of things to come. Trends Pharmacol Sci 28: 567\u2013572.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp2015148_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.bjp.0707349","volume":"152","author":"RA Ross","year":"2007","unstructured":"Ross RA (2007b). Tuning the endocannabinoid system: allosteric modulators of the CB1 receptor. Br J Pharmacol 152: 565\u2013566.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2015148_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.107.119941","volume":"322","author":"R Russo","year":"2007","unstructured":"Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A et al (2007). The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. J Pharmacol Exp Ther 322: 236\u2013242.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2015148_CR49","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/nn.2616","volume":"13","author":"JE Schlosburg","year":"2010","unstructured":"Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG et al (2010). Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 13: 1113\u20131119.","journal-title":"Nat Neurosci"},{"key":"BFnpp2015148_CR50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.phrs.2011.04.010","volume":"64","author":"NR Sciolino","year":"2011","unstructured":"Sciolino NR, Zhou W, Hohmann AG (2011). Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Pharmacol Res 64: 226\u2013234.","journal-title":"Pharmacol Res"},{"key":"BFnpp2015148_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K et al (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215: 89\u201397.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFnpp2015148_CR52","doi-asserted-by":"publisher","first-page":"12198","DOI":"10.1073\/pnas.96.21.12198","volume":"96","author":"JM Walker","year":"1999","unstructured":"Walker JM, Huang SM, Strangman NM, Tsou K, Sanudo-Pena MC (1999). Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci USA 96: 12198\u201312203.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2015148_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.lfs.2006.08.017","volume":"80","author":"JL Wiley","year":"2006","unstructured":"Wiley JL, Razdan RK, Martin BR (2006). Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. Life Sci 80: 24\u201335.","journal-title":"Life Sci"},{"key":"BFnpp2015148_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuropharm.2007.06.003","volume":"54","author":"LE Wise","year":"2008","unstructured":"Wise LE, Cannavacciulo R, Cravatt BF, Martin BF, Lichtman AH (2008). Evaluation of fatty acid amides in the carrageenan-induced paw edema model. Neuropharmacology 54: 181\u2013188.","journal-title":"Neuropharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2015148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2015148","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2015148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T08:14:58Z","timestamp":1748420098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2015148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,8]]},"references-count":54,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFnpp2015148"],"URL":"https:\/\/doi.org\/10.1038\/npp.2015.148","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725540640.793510181","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.725540640.793510011","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,8]]},"assertion":[{"value":"13 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}